Neimeth International Pharmaceuticals PLC Stock: price and insider trades · Nigeria
3 insiders bought €3,257 of shares over the last 90 days, the latest by CLINOSCOPE SERVICES LIMITED, filed 06 Oct 2026.
Neimeth International Pharmaceuticals PLC: what insiders have been doing
This page follows insider dealings at Neimeth International Pharmaceuticals PLC as filed with Nigerian Exchange (NGX). Over the twelve months to 18 October 2026, 27 filings were filed, from 8 insiders.
Open-market activity splits into 13 purchases totalling €21k and 4 sales; 6 insiders sit on the buying side and 2 insiders on the selling side. The amount is not disclosed for 14 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 3 major shareholders, 2 board members and 1 chief executive. One trade stands out by size: a purchase of €8,772 from Okoruwa, Eric, disclosed on 1 July 2026.
The last purchase on record was published on 6 October 2026, which is 33 days ago. Between a trade and the moment it shows up on Nigerian Exchange (NGX), the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (54 companies, median 6 filings), a count of 27 filings is above the norm. Looking back to 2025, when coverage begins, insiders filed 13 purchases and 4 sales.
This summary is built from Nigerian Exchange (NGX) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- Ordinary SharesNGXISIN NGNEIMETH001NGX:257bab5dd41c1a044bd25925b46531237018321eCanonical exit: 4 Jan 2027 (T+90)
- @ €0.0046Ordinary SharesNGXISIN NGNEIMETH001NGX:f7c2e4e890048d497b2712f5811b9c6159f0b7cd
- ●Executives0NGX
- 714,285 shares@ NGN 6.75100.0% of flowOrdinary SharesNGXISIN NGNEIMETH001NGX:0c640a18c83360f0fcb786cd98c68caa3f763bc5Canonical exit: 16 Dec 2026 (T+90)
- ●Executives0NGX
- @ €0.0046Ordinary SharesNGXISIN NGNEIMETH001NGX:66b5c9fd13984de0d3c56ed75654e9508d3a9df1Canonical exit: 16 Dec 2026 (T+90)
- ●Executives0NGX
- @ €0.007Ordinary SharesNGXISIN NGNEIMETH001NGX:91ba3ebd173d7e95e645fc09c882efc213157e02Canonical exit: 1 Sept 2026 (T+90)
- ●Executives0NGX
- @ €0.005Ordinary SharesNGXISIN NGNEIMETH001NGX:90fcebce694b1a47e42b020c327c5a8f7f37fd54Canonical exit: 2 Nov 2026 (T+90)
- @ €0.0049Ordinary SharesNGXISIN NGNEIMETH001NGX:a478a0d0900dce9bac124c75c37d4a4b46f02597Canonical exit: 28 Sept 2026 (T+90)
- Ordinary SharesNGXISIN NGNEIMETH001NGX:4dc397a0f4e15aab13c22aea7f1b72d37b90da29Canonical exit: 28 Sept 2026 (T+90)
- 1,606,766 shares@ NGN 8.50Ordinary SharesNGXISIN NGNEIMETH001NGX:a02b947c559162579db98bc05d22aab8951f11abCanonical exit: 21 Sept 2026 (T+90)
- 1,606,766 shares@ NGN 8.50100.0% of flowOrdinary SharesNGXISIN NGNEIMETH001NGX:1e9de9e5cdc89dbdb9e56d99e9050a393cf739afCanonical exit: 29 Sept 2026 (T+90)
- 1,606,766 shares@ NGN 8.50100.0% of flowNGXISIN NGNEIMETH001NGX:d86a22a5f4a2dd3be7f1bb152b2c4ad353e6d875
- @ €0.0233Ordinary SharesNGXISIN NGNEIMETH001NGX:79ed90edcf55fdc9b69744b1fc6ab958ca3025e6Canonical exit: 13 Sept 2019 (T+90)
- ●Executives0NGX
- Ordinary SharesNGXISIN NGNEIMETH001NGX:32ae259f6dc9edf83754b9dcec28cc524a21019eCanonical exit: 13 Sept 2019 (T+90)
- @ €0.007Ordinary SharesNGXISIN NGNEIMETH001NGX:9173d14e834eef76d7a6bec1e636b99345c01233
- ●Executives0NGX
- Ordinary SharesNGXISIN NGNEIMETH001NGX:b6ad7c89871d8573c69a0b40994ddbe064d30db0
- @ €0.0065Ordinary SharesNGXISIN NGNEIMETH001NGX:63cc67a0ff12339396a57c721ab0a6d741a05ec8Canonical exit: 30 Aug 2026 (T+90)
- @ €0.0066Ordinary SharesNGXISIN NGNEIMETH001NGX:f6dac232436d723c32dfca339319b889045bb7cb
- @ €0.0066Ordinary SharesNGXISIN NGNEIMETH001NGX:d4643ca49c48fc69794d7194b1a2b956675591bdCanonical exit: 26 Aug 2026 (T+90)
- ●Executives0NGX
25 of 32 declarations
About Neimeth International Pharmaceuticals PLC
Neimeth International Pharmaceuticals PLC is a Nigerian pharmaceutical company focused on the production of medicines. It is listed on the Nigerian Stock Exchange under the symbol XNSA.